companydata.dkcompanydata.dk

Center for Clinical and Basic Research A/S: Financial statements 2023

CVR: 21142743

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Center for Clinical and Basic Research A/S (CVR 21142743) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 16,070,761 and a net result of DKK 17,387,280 compared with DKK 2,735,461 the year before. That is a decrease of 81.8% compared with the year before. The profit margin was 108.2%. Equity in the 2023 report amounted to DKK -21,662,819. The company had 8 employees in the financial year.

Revenue
DKK 16,070,761
Gross Profit
DKK 3,885,231
Profit/Loss
DKK 17,387,280
Equity
DKK -21,662,819
Total Assets
DKK 74,083,681
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
202316.1M3.9M17.4M-21.7M8
202288.1M23M2.7M-35.7M54
202194.4M26M-23.8M-37.6M28
2020120.6M59M4.8M-18.7M54
201940.6M-22.3M-47.4M-22.3M28

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Center for Clinical and Basic Research A/S: The 2022 annual report is outAug 4, 2023

Center for Clinical and Basic Research A/S has published its annual report for 2022. Revenue came to DKK 88,097,967, and the net result was DKK 2,735,461.

Center for Clinical and Basic Research A/S appoints new auditorJun 22, 2023

As of June 22, 2023, Ecovis Danmark statsautoriseret revisionsinteressentskab has been appointed auditor of Center for Clinical and Basic Research A/S.

Auditor steps down at Center for Clinical and Basic Research A/SJun 22, 2023

As of June 22, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of Center for Clinical and Basic Research A/S.

Petrus Thomas Adrianus van der Zande joins the board of Center for Clinical and Basic Research A/SMay 15, 2023

As of May 15, 2023, Petrus Thomas Adrianus van der Zande has joined the board of directors of Center for Clinical and Basic Research A/S.

Richard Stuart Harris leaves the board of Center for Clinical and Basic Research A/SMay 15, 2023

As of May 15, 2023, Richard Stuart Harris has left the board of directors of Center for Clinical and Basic Research A/S.

Jason James Berg joins the board of Center for Clinical and Basic Research A/SJan 31, 2023

As of January 31, 2023, Jason James Berg has joined the board of directors of Center for Clinical and Basic Research A/S.

Dustin Nathan Owen leaves the board of Center for Clinical and Basic Research A/SJan 31, 2023

As of January 31, 2023, Dustin Nathan Owen has left the board of directors of Center for Clinical and Basic Research A/S.

Jason James Berg joins Center for Clinical and Basic Research A/S as adm. dir.Jan 31, 2023

As of January 31, 2023, Jason James Berg is registered as adm. dir. of Center for Clinical and Basic Research A/S.

Dustin Nathan Owen steps down as adm. dir. of Center for Clinical and Basic Research A/SJan 31, 2023

As of January 31, 2023, Dustin Nathan Owen has stepped down as adm. dir. of Center for Clinical and Basic Research A/S.

About Center for Clinical and Basic Research A/S

Center for Clinical and Basic Research A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named SYNARC A/S and DODONA A/S. The management consists of Victor Richard Lopes. The board consists of Petrus Thomas Adrianus van der Zande (chair), Julia Lauren Chen and Victor Richard Lopes. The company is owned by Synexus Compass, Inc.. The company has 1 employee (2024). In 2025, the company reported revenue of DKK 2,133,368 and a net result of DKK -7,411,708 compared with DKK 10,625,435 the year before. Equity in the 2025 report amounted to DKK -16,371,637.

Source: annual report 2025, Danish Business Authority